The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Open accessAbstract
Aptamers are short, single-stranded oligonucleotides that bind to specific target molecules. The shape-forming feature of single-stranded oligonucleotides provides high affinity and excellent specificity toward targets. Hence, aptamers can be used as analogs of antibodies. In December 2004, the US Food and Drug Administration approved the first aptamer-based therapeutic, pegaptanib (Macugen), targeting vascular endothelial growth factor, for the treatment of age-related macular degeneration. Since then, however, no aptamer medication for public health has appeared. During these relatively silent years, many trials and improvements of aptamer therapeutics have been performed, opening multiple novel directions for the therapeutic application of aptamers. This review summarizes the basic characteristics of aptamers and the chemical modifications available for aptamer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the increasing recognition of the vital role played by RNA in transferring cellular information and regulating genes, targeting RNAs has become an exciting opportunity to therapeutically modulate cellular processes linked to previously “undruggable” protein targets.550–552”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [552]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,421
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 2×
“reported that sgRNA has loop regions outside of Cas9, and a natural RNA aptamer could be integrated [92].”
BackgroundTherapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,629
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,539
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Ruckman, J., Green, L. S., Beeson, J., Waugh, S. M., Gillette, W. L., Henninger, D. D., Claesson, L., & Janjić, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 759
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–305 of 305
Selection and characterization of ssDNA aptamers targeting tick-borne encephalitis virus particles
Fujii, Y., Shinozaki, T., Hirano, M., Fukuta, M., Sakamoto, T., & Yoshii, K. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103138
Simple, Fast and Cheap Pb2+ and Hg2+ Detection in Liquid Media Using EGOFET-Based Aptasensors
Keshek, A. K., Skvortsov, D. A., Poimanova, O. Y., Orlov, V. N., Oleynikov, I. P., Stiazhkina, M. S., Turashev, A. D., Zavyalova, E. G., & Agina, E. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219711
Nonclinical Evaluation Studies of Nucleic Acid Drugs
(2026) · Elsevier eBooks · doi:10.1016/b978-0-443-48612-8.00017-8
Bora, N. R., Singh, S., Narang, J., & Kumar, S. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154841
Metadata
- Authors
- Adachi, T., & Nakamura, Y.
- Affiliations
- RIBOMIC Inc., Minato-ku, Tokyo 108-0071, Japan
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Adachi, Tatsuo
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-11-21
- Volume
- 24
- Issue
- 23
- Pages
- 4229
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6930564
- OpenAlex
- W2989998401
- Cited by
- 300
- References
- 115
- Citations by year
- 2026: 33 · 2025: 50 · 2024: 59 · 2023: 53 · 2022: 44 · 2021: 42 · 2020: 19
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Tokyo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- aptamers, aptamer therapeutics, chemical modification, oligonucleotide chemistry, pegaptanib, vascular endothelial growth factor, age-related macular degeneration, drug delivery
- MeSH terms
- Animals, Humans, Infections, Neoplasms, Aptamers, Nucleotide, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
